Monday, Nov 16, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Business | Eli Lilly Out With Indias First Alzheimers Drug Lormalzi

Eli-Lilly out with India’s first Alzheimer’s drug, Lormalzi

Eli-Lilly has launched India’s first disease-modifying Alzheimer’s drug, donenemab, under the brand name Lormalzi. Approved by the CDSCO in 2025, the treatment aims to slow cognitive decline in early-stage patients, though high costs and healthcare limitations may affect accessibility.

By Telangana Today
Updated On - 14 May 2026, 05:21 PM
Eli-Lilly out with India’s first Alzheimer’s drug, Lormalzi
whatsapp facebook twitter telegram

By Harikrishnan R

Hyderabad: Pharmaceutical giant Eli-Lilly is again in the spotlight with the launch of India’s first Alzheimer’s disease-modifying drug, donenemab, under the brand name ‘Lormalzi’.


The monthly administered intravenous drug works by breaking down beta-amyloid protein plaques (protein clusters) accumulated in the brain, a primary cause of Alzheimer’s disease.

Clinical trials have shown that the breakdown and removal of these protein clusters slows cognitive decline in early-stage patients by almost 30 to 35 per cent.

Donenemab, an artificially engineered monoclonal antibody, was developed by Eli-Lilly in the 2010s and was first approved for medical use in the US in 2024.

The Central Drugs Standard Control Organization (CDSCO) approved the drug for medical use in November 2025 based on the global Phase III trial data, waiving local trials due to the high unmet need for the drug in India.

Priced at Rs 91,688 per dose, Lormalzi’s cost is likely to be the biggest obstacle for patients seeking access to the drug.

As of 2026, close to 9 million people in India suffer from dementia, with Alzheimer’s accounting for almost 75 per cent of these cases. Studies show that this number could double by 2036.

In light of the growing burden of Alzheimer’s disease, the introduction of the drug in the country is seen as a necessary step.

It is also important to note that there are several limitations to the effective implementation of the drug in India.

Treatment with Lormalzi requires early detection of the disease, something that rarely happens among patients in India.

There is also a need to screen patients for compatibility with the drug to prevent adverse effects.

The current health infrastructure in the country may not yet be ready for this, and the cost of the drug makes it even less accessible.

At the same time, the president and general manager of Eli-Lilly India, Winselow Tucker, has announced an Alternate Access Programme to provide broader access for eligible patients in the country.

Join Our Whatsapp Channel
  • Follow Us :
As preferred source
  • Tags
  • Alternate Access Programme
  • Eli Lilly
  • Eli-Lilly India
  • Hyderabad

Related News

  • Hyderabad celebrates Chhath Puja with prayers at major water bodies

    Hyderabad celebrates Chhath Puja with prayers at major water bodies

  • EAGLE Force traces e-cigarette supplies from Kolkata to Telangana

    EAGLE Force traces e-cigarette supplies from Kolkata to Telangana

  • TGTDC launches Wings & Wilderness nature walk at Nanakramguda

    TGTDC launches Wings & Wilderness nature walk at Nanakramguda

  • Woman accuses businessman of sexual exploitation, blackmail

    Woman accuses businessman of sexual exploitation, blackmail

Latest News

  • Jensen Huang explores return as Nvidia CEO amid comeback campaign

    32 seconds ago
  • Chiranjeevi submits memorandum seeking safeguards against AI impersonation

    7 minutes ago
  • Telangana revises SSC Public Examinations 2027 fee payment deadlines

    43 minutes ago
  • Former India captain Shabbir Ali meets AFC Secretary General in Kuala Lumpur

    46 minutes ago
  • Dr Anil Kumar assumes charge as Telangana State Road Transport Corporation VC and MD

    1 hour ago
  • Varanasi post-production, CG work progressing; dubbing yet to begin

    1 hour ago
  • Hyderabad: Fire at Mandi King spreads to neighbouring Hotel Zunera in Tolichowki

    1 hour ago
  • Amitabh Bachchan recalls near-drowning experience while kayaking in Nepal

    2 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

Telangana Today App